Navigation Links
Women More Persistent with Monthly Osteoporosis Treatment

Once a month osteoporisis drug and extra telephone support from trained nurses has met with 47 per cent greater persistence among women for their drug treatment// than those who took a weekly tablet, according to a study in the August issue of IJCP, the International Journal of Clinical Practice.

103 primary care centres across the UK took part in the PERSIST study between January 2005 and January 2006, with 1,076 women each agreeing to participate for a six-month period.

542 were prescribed a single 70mg dose of alendronate once a week and the remainder received a single monthly 150mg dose of ibandronate and were enrolled in a free patient support programme designed to complement the drug.

The monthly ibandronate group received a welcome pack providing basic information about osteoporosis and a monthly reminder call from a trained nurse one to three days before the dose was due.

The nurses also used the opportunity to confirm dosing instructions, provide further information about osteoporosis and stress the importance of adhering to the treatment regime.

835 women completed the study, leaving 440 in the monthly ibandronate group and 395 in the weekly alendronate group.

Of these, just under 57 per cent of patients receiving monthly ibandronate tablets, together with patient support, were taking the medication after six months. The persistence rate for patients on weekly alendronate tablets was 39 per cent.

"Getting patients to continue taking prescribed medication is a major problem for healthcare professionals" says lead author Dr Alun Cooper, a family doctor from the Bridge Medical Centre in Crawley, UK.

"The World Health Organization estimates that only 50 per cent of patients with chronic diseases in developing countries stick to treatment regimes. And the American Heart Association has identified failing to take medication correctly as the number one problem
'"/>




Page: 1 2

Related medicine news :

1. Women suffer from sexual dysfunction too
2. Women find difficulty in calling it Quits
3. Women recognise faces better
4. Women more susceptible to brain damage from ecstasy
5. Good News For Women With Gestational Diabetes
6. Unsatisfactory Grade On Womens Health Issues
7. Risk for Pregnant Women
8. Womens strong sense of smell
9. Women need to exercise more to prevent obesity
10. Women benefit from consuming fish
11. Women are at risk with raised cholesterol

Post Your Comments:
(Date:11/29/2009)...nal healthcare,s uncertain future and rising costs...are. Affordable Acupuncture Scottsdale answers the... 29, 2009 -- Affordable Acupuncture, LLC opened in...en met with enthusiasm and gratitude. Its increasi...to two things, need and cost. "As far as I&r...
(Date:11/28/2009)...d to affect circadian rhythm, , , F...ggests that an internal body clock that goes on th...polar disorder in children. , The finding resu...152 children with bipolar disorder, which can make...children without the disorder. They linked variati...
(Date:11/27/2009)...firm Replikins Ltd. today issued its latest bioche... shows that the lethality of the virus has dropped...s current outbreak in the spring of 2009 to restin... The H1N1 infectivity count, however, remains incr...ovember 27, 2009 -- Biotech firm Replikins Ltd., w...
(Date:11/27/2009)...rance, Nov. 27 Team Garmin-Slipstr...dedicated to ethical sporting and developing the n...ay that it will become Team Garmin-Transitions wit...nsor of the team. Transitions Optical is the world...ing the most advanced photochromic technology in t...
(Date:11/27/2009)...ed medical, economic burdens, study predicts , ...umber of people with diabetes in the United States...ew study predicts. , That would bring the total...ease, up from 23.7 million today. , , At the sam...will triple, the study also warns, rising from an ...
Breaking Medicine News(10 mins):Health News:Affordable Acupuncture Greeted with Open Arms by Scottsdale and Phoenix Communities 2Health News:Bipolar Disorder May Be Tied to Body Clock 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3
... that tight glucose control can lower the risk of ...ype 1. Keeping a tight glucose control on the...abetes is to keep their blood sugar as close to th...adjusting medication according to the daily food i...
...n D and calcium can ward off an attack of premenst... (PMS) is the set of symptoms that affect a lot of... Some common symptoms of PMS are depression, feeli...ted because of their physical conditions. Res...
...und the occurrence diabetic retinopathy in a numbe...betes type 2. Diabetes type 2 happens when bo...ar. As this happens the body becomes unable to pro...ood glucose existent in patients, but the levels a...
...n, researchers have shown that twisting the graft ...rk better and last longer. In using a graft t...rosthetic tubes. Similar tubes are also used when ... blood flows twisting and turning as the artery go...
...en able to generate human skin tissues, which have.... The researchers for the study feel that this wil...otential of genes in development of skin cancer. ...ord University School of Medicine have introduced ...
... people with low birth weight may help themselves ...iet and controlling their body weights. Diabe...he metabolism of blood glucose and impaired functi...ence and age related factors. Recent studies have ...
Other Medicine News:
(Date:11/29/2009)... FUJIFILM Medical Systems USA, Inc. is pleased to ...l DR cassette, at the 2009 Radiological Society of...ny clinical environment, FDR D-EVO uses an innovat...film,s trademark image quality and outstanding fle...o transition to DR without modification to the exa...
(Date:11/29/2009)... Researchers using functional magnetic resonance i... that men and women respond differently to positiv...nted today at the annual meeting of the Radiologic... direct more attention to sensory aspects of emoti...implications for required action, whereas women di...
(Date:11/27/2009)...swire/ -- ACUO TECHNOLOGIES, developers of high-pe...migration tools and services, is pleased to announ...ice has approved a patent application for an "Asse... Acuo Technologies is pleased to add the U.S. pate...eneral, the granted patent application broadly pro...
Breaking Medicine Technology:FUJIFILM's DR Cassette Makes World Debut 2New Study Finds Men and Women May Respond Differently to Danger 2New Study Finds Men and Women May Respond Differently to Danger 3Acuo Technologies Announces Patent for Asset Communication Format Within a Computer Network 2Treating ROP in tiny preemies 3B better glaucoma follow up in urban clinic 60035 1Treating ROP in tiny preemies 3B better glaucoma follow up in urban clinic 60035 2Treating ROP in tiny preemies 3B better glaucoma follow up in urban clinic 60035 3Orexigen 28R 29 Therapeutics Presents New Data Showing Weight Loss with Contrave Significantly Improves Important Markers of Cardiometabolic Risk 60031 1Orexigen 28R 29 Therapeutics Presents New Data Showing Weight Loss with Contrave Significantly Improves Important Markers of Cardiometabolic Risk 60031 2Orexigen 28R 29 Therapeutics Presents New Data Showing Weight Loss with Contrave Significantly Improves Important Markers of Cardiometabolic Risk 60031 3Orexigen 28R 29 Therapeutics Presents New Data Showing Weight Loss with Contrave Significantly Improves Important Markers of Cardiometabolic Risk 60031 4Orexigen 28R 29 Therapeutics Presents New Data Showing Weight Loss with Contrave Significantly Improves Important Markers of Cardiometabolic Risk 60031 5Orexigen 28R 29 Therapeutics Presents New Data Showing Weight Loss with Contrave Significantly Improves Important Markers of Cardiometabolic Risk 60031 6Orexigen 28R 29 Therapeutics Presents New Data Showing Weight Loss with Contrave Significantly Improves Important Markers of Cardiometabolic Risk 60031 7Gene Therapy Offers Hope for Severe Hereditary Eye Disease 60029 1Gene Therapy Offers Hope for Severe Hereditary Eye Disease 60029 2
...AN FRANCISCO, June 9 Halozyme Therapeutics,Inc. (...oping and,commercializing products targeting the e...ata for the company,s diabetes mellitus program at...ic Sessions. The data,showed that combining the co...e enzyme (rHuPH20) with Humulin R(R) (regular insu...
...SPIRE IRB Is Exhibiting at Bio International Conve... 17-20, Currently, over 54,255 Trials with L... Place, SAN DIEGO, June 9 ASPI...nt Review Board (IRB), is,responsible for overseei...of people participating in clinical trials. ASPIRE...
Other Medicine Technology:Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability 2Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability 3Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability 4Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability 5ASPIRE Independent Review Board Announces 10 Ways to Protect Participants' Rights in Clinical Drug Trials and Optimize Results From Research 2ASPIRE Independent Review Board Announces 10 Ways to Protect Participants' Rights in Clinical Drug Trials and Optimize Results From Research 3
Penicillin-Streptomycin Mixture
PEN-STREP, 100X
Gentamicin, 10 mg/ml
GENTAMICIN SULFATE, 1000X
Medicine Products: